185 related articles for article (PubMed ID: 15097034)
1. Nocturnal acid breakthrough: pH, drugs and bugs.
Tutuian R; Katz PO; Castell DO
Eur J Gastroenterol Hepatol; 2004 May; 16(5):441-3. PubMed ID: 15097034
[TBL] [Abstract][Full Text] [Related]
2. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
[TBL] [Abstract][Full Text] [Related]
3. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.
Fackler WK; Ours TM; Vaezi MF; Richter JE
Gastroenterology; 2002 Mar; 122(3):625-32. PubMed ID: 11874994
[TBL] [Abstract][Full Text] [Related]
5. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
[TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
Katz PO; Anderson C; Khoury R; Castell DO
Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
[TBL] [Abstract][Full Text] [Related]
7. Drugs, bugs, and esophageal pH profiles.
Robinson M
Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.
Ours TM; Fackler WK; Richter JE; Vaezi MF
Am J Gastroenterol; 2003 Mar; 98(3):545-50. PubMed ID: 12650785
[TBL] [Abstract][Full Text] [Related]
9. Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy.
Sato K
Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1121-6. PubMed ID: 16845517
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal acid breakthrough - approach to management.
Tutuian R; Castell DO
MedGenMed; 2004 Oct; 6(4):11. PubMed ID: 15775838
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.
Orr WC; Harnish MJ
Aliment Pharmacol Ther; 2003 Jun; 17(12):1553-8. PubMed ID: 12823159
[TBL] [Abstract][Full Text] [Related]
12. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.
Qvigstad G; Arnestad JS; Brenna E; Waldum HL
Scand J Gastroenterol; 1998 Dec; 33(12):1244-8. PubMed ID: 9930386
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori infection influences nocturnal gastric acid breakthrough.
Katsube T; Adachi K; Kawamura A; Amano K; Uchida Y; Watanabe M; Kinoshita Y
Aliment Pharmacol Ther; 2000 Aug; 14(8):1049-56. PubMed ID: 10930899
[TBL] [Abstract][Full Text] [Related]
14. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.
Peters FT; Kuipers EJ; Ganesh S; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Aliment Pharmacol Ther; 1999 Jul; 13(7):921-6. PubMed ID: 10383527
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease.
Ghoshal UC; Blaachandran A; Rai S; Misra A
Indian J Gastroenterol; 2022 Aug; 41(4):405-414. PubMed ID: 35771390
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal gastric acid breakthrough on proton pump inhibitors.
Savarino V; Mela GS
Aliment Pharmacol Ther; 1999 Jul; 13(7):977-8. PubMed ID: 10383534
[No Abstract] [Full Text] [Related]
17. Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease.
Martínek J; Kuzela L; Spicák J; Vavrecka A
Aliment Pharmacol Ther; 2000 Aug; 14(8):979-90. PubMed ID: 10930891
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
Nzeako UC; Murray JA
Aliment Pharmacol Ther; 2002 Jul; 16(7):1309-16. PubMed ID: 12144581
[TBL] [Abstract][Full Text] [Related]
19. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
